December 16, 2024 – INCATE (INCubator for Antibacterial Therapies in Europe) is pleased to announce that two ventures have been awarded Stage II funding in its latest round: Kinzbio and the BamA inhibitor project from [...]
More news
December 6th 2023 – INCATE (the INCubator for Antibacterial Therapies in Europe) and Kineticos AMR [...]
The INCATE Selection Committee selected the last 4 new ventures for Stage I support in [...]
On November 8th 2023 we organized INCATEs 3rd Entrepreneurs Club about ways to get funding [...]
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways [...]
November 1st, 2023 - INCATE (the INCubator for Antibacterial Therapies in Europe) and BIOASTER, the [...]
The Entrepreneurs Club is back! Join this 3rd INCATE Entrepreneurs Club on "Creative Funding - [...]
Nijmegen, 12th September 2023 - By the occasion of the World Sepsis Day, SurvivX is [...]
The next INCATE's Selection Committee is coming up and we are now accepting applications for [...]
